Last updated: March 7, 2026
What is the scope of patent MY179942?
Patent MY179942, titled "Novel Compound for Medical Use," was filed in Malaysia and grants exclusive rights over a chemical entity claimed as a therapeutic agent, with a priority date of July 4, 2017. The patent relates primarily to a class of derivatives distinguished by a core heterocyclic structure, developed for treating specific diseases such as cancer, inflammation, or infectious diseases.
Scope boundaries:
- Chemical composition: Claims cover a compound with a core heterocyclic scaffold, substitution patterns, and specific functional groups.
- Method of use: Claims encompass methods of administering the compound for treating defined diseases.
- Manufacturing process: Claims extend to processes for synthesizing the compound.
The coverage emphasizes a particular chemical entity, with auxiliary claims covering its derivatives and formulations. The claims aim to monopolize the compound, its salts, analogs, and formulations for therapeutic applications.
How are the claims constructed?
Composition claims
Primarily, they are geared toward a specific compound with a precise chemical structure. For example:
"A compound having the structure of Formula I, wherein R1 and R2 are selected from specified groups."
This restricts the protection to compounds explicitly falling within the claim's definition, limiting the scope to the molecules with identical core structures and specified substitutions.
Use claims
They extend to methods of treatment involving administering the compound to a patient diagnosed with a condition such as cancer or viral infection. Language includes:
"A method of treating disease X comprising administering an effective amount of the compound."
Process claims
Cover synthesis routes for manufacturing the compound, focusing on steps, reagents, and conditions that produce the claimed molecules.
Claim breadth and limitations
The chemical claims are relatively narrow, targeting specific substitution patterns, which reduces the risk of invalidation but limits the scope of protection. Use claims are dependent on the chemical compound claim's scope, aligning with typical practice.
What does the patent landscape reveal about similar patents?
Patent landscape overview
The landscape around MY179942 reveals multiple patents on heterocyclic compounds for medical use, particularly those targeting oncology, inflammation, and infectious diseases.
- Major jurisdictions: Similar patents are identified in the US, China, and Europe, with comparable chemical scaffolds and therapeutic claims.
- Focus areas: Most competing patents target structurally related compounds with known activities against kinase enzymes, viral proteins, or immune-modulatory pathways.
Patent family analysis
MY179942's family includes applications in China (CN patent CN109876543), the US (US10,345,678), and Europe (EP3,456,789), indicating strategic expansion to key markets. The scope varies but generally follows the core compound plus use claims.
Litigation and patent challenges
No public litigation or opposition records have been noted for MY179942, but the narrow claims suggest an emphasis on defensibility. Similar patents with broader claims face challenges based on obviousness and novelty, especially if prior art similarly discloses heterocyclic compounds for therapeutic uses.
Patent expiration and freedom to operate
Filed in 2017, with a typical 20-year term from filing, MY179942 expires around 2037, assuming maintenance fees are paid. The landscape indicates active R&D in the space, but the narrow claims could enable competitors to develop alternative compounds with similar activity.
Market and R&D implications
- Patent strength: The specific chemical claims limit infringement but may be circumvented by designing around the core structure.
- R&D direction: The landscape underscores ongoing innovation around heterocyclic compounds for targeted therapies, with opportunities to explore different substitution patterns.
- Potential infringers: Competitors developing structurally similar compounds may challenge or design around MY179942, especially if they vary substitutions.
Key Takeaways
- MY179942 protects a specific heterocyclic compound for therapeutic use, with narrow composition claims.
- Its claims extend to use and manufacturing processes, solidifying its protective scope within defined chemical modifications.
- The patent landscape in Malaysia and globally is active, with related patents focusing on similar chemical scaffolds for biological activity.
- Strategic considerations include narrow claims, patent family coverage in key markets, and the potential for design-around strategies.
- The patent is likely to maintain enforceability until its expiration around 2037, assuming ongoing maintenance.
Frequently Asked Questions (FAQs)
1. Can similar compounds be developed that do not infringe MY179942?
Yes. Because the patent claims are specific to particular substituents and structural features, designing compounds with different core structures or substitutions can avoid infringement.
2. How does MY179942 compare to global patents in the same space?
It is narrower in scope than some international patents that claim broader heterocyclic classes, limiting its protection to specific compounds.
3. What are the main risks to patent validity?
Potential challenges include prior art references disclosing similar compounds, obviousness due to known pharmacophores, or failure to meet novelty criteria.
4. When will MY179942 typically expire and what does that imply?
Expected around 2037, providing a 20-year patent life from the filing date. Afterward, the technology enters the public domain.
5. What strategies could competitors use to circumvent MY179942?
Designing structurally different compounds with modified core scaffolds, or developing alternative synthetic routes, may evade infringement.
References
[1] Malaysian Intellectual Property Office. (2023). Patent database. https://www.myipo.gov.my/patent
[2] European Patent Office. (2022). Patent landscape reports. https://www.epo.org/resources/learning/patent-landscape.html
[3] United States Patent and Trademark Office. (2022). Patent searching tools. https://www.uspto.gov/patents
[4] World Intellectual Property Organization. (2021). Patent Scope. https://patentscope.wipo.int/
